ORIC Pharmaceuticals to Host Call on Enozertinib Data at ESMO

ORIC Pharmaceuticals said a conference call and webcast will take place Friday, October 23, 2026, at 8:00 a.m. ET, featuring Dr. Joshua Sabari discussing enozertinib clinical data and its potential in first-line NSCLC patients with EGFR atypical mutations.